List of Excipients in API prednisolone acetate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing prednisolone acetate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Alcon Laboratories Inc | OMNIPRED | prednisolone acetate | 0065-0638 | BENZALKONIUM CHLORIDE | |
| Alcon Laboratories Inc | OMNIPRED | prednisolone acetate | 0065-0638 | CITRIC ACID MONOHYDRATE | |
| Alcon Laboratories Inc | OMNIPRED | prednisolone acetate | 0065-0638 | EDETATE DISODIUM | |
| Alcon Laboratories Inc | OMNIPRED | prednisolone acetate | 0065-0638 | GLYCERIN | |
| Alcon Laboratories Inc | OMNIPRED | prednisolone acetate | 0065-0638 | HYPROMELLOSES | |
| Alcon Laboratories Inc | OMNIPRED | prednisolone acetate | 0065-0638 | POLYSORBATE 80 | |
| Alcon Laboratories Inc | OMNIPRED | prednisolone acetate | 0065-0638 | SODIUM HYDROXIDE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for prednisolone acetate
Excipient focus: BENZALKONIUM CHLORIDE
prednisolone acetate drug variants containing BENZALKONIUM CHLORIDE
prednisolone acetate drug variants not containing BENZALKONIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | prednisolone acetate | 51672-1338 |
| >Company | >Ingredient | >NDC |
Excipient focus: BORIC ACID
prednisolone acetate drug variants containing BORIC ACID
prednisolone acetate drug variants not containing BORIC ACID
Excipient focus: BUTYLPARABEN
prednisolone acetate drug variants containing BUTYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | prednisolone acetate | 51672-1338 |
| >Company | >Ingredient | >NDC |
prednisolone acetate drug variants not containing BUTYLPARABEN
Excipient focus: CARBOMER HOMOPOLYMER TYPE B
prednisolone acetate drug variants containing CARBOMER HOMOPOLYMER TYPE B
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | prednisolone acetate | 51672-1338 |
| >Company | >Ingredient | >NDC |
prednisolone acetate drug variants not containing CARBOMER HOMOPOLYMER TYPE B
Excipient focus: CITRIC ACID MONOHYDRATE
prednisolone acetate drug variants containing CITRIC ACID MONOHYDRATE
prednisolone acetate drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: EDETATE DISODIUM
prednisolone acetate drug variants containing EDETATE DISODIUM
prednisolone acetate drug variants not containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
prednisolone acetate drug variants containing GLYCERIN
prednisolone acetate drug variants not containing GLYCERIN
Excipient focus: HYPROMELLOSE
prednisolone acetate drug variants containing HYPROMELLOSE
prednisolone acetate drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSES
prednisolone acetate drug variants containing HYPROMELLOSES
prednisolone acetate drug variants not containing HYPROMELLOSES
Excipient focus: POLOXAMER 188
prednisolone acetate drug variants containing POLOXAMER 188
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | prednisolone acetate | 51672-1338 |
| >Company | >Ingredient | >NDC |
prednisolone acetate drug variants not containing POLOXAMER 188
Excipient focus: POLYSORBATE 80
prednisolone acetate drug variants containing POLYSORBATE 80
prednisolone acetate drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | prednisolone acetate | 51672-1338 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
prednisolone acetate drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | prednisolone acetate | 51672-1338 |
| >Company | >Ingredient | >NDC |
prednisolone acetate drug variants not containing PROPYLENE GLYCOL
Excipient focus: SODIUM BISULFITE
prednisolone acetate drug variants containing SODIUM BISULFITE
prednisolone acetate drug variants not containing SODIUM BISULFITE
Excipient focus: SODIUM CHLORIDE
prednisolone acetate drug variants containing SODIUM CHLORIDE
prednisolone acetate drug variants not containing SODIUM CHLORIDE
Excipient focus: SODIUM CITRATE
prednisolone acetate drug variants containing SODIUM CITRATE
prednisolone acetate drug variants not containing SODIUM CITRATE
Excipient focus: SODIUM HYDROXIDE
prednisolone acetate drug variants containing SODIUM HYDROXIDE
prednisolone acetate drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM PHOSPHATE, DIBASIC
prednisolone acetate drug variants containing SODIUM PHOSPHATE, DIBASIC
prednisolone acetate drug variants not containing SODIUM PHOSPHATE, DIBASIC
Excipient focus: SUCRALOSE
prednisolone acetate drug variants containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | prednisolone acetate | 51672-1338 |
| >Company | >Ingredient | >NDC |
prednisolone acetate drug variants not containing SUCRALOSE
Excipient focus: WATER
prednisolone acetate drug variants containing WATER
prednisolone acetate drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
